Literature DB >> 9537322

Primary afferent tachykinins are required to experience moderate to intense pain.

Y Q Cao1, P W Mantyh, E J Carlson, A M Gillespie, C J Epstein, A I Basbaum.   

Abstract

The excitatory neurotransmitter glutamate coexists with the peptide known as substance P in primary afferents that respond to painful stimulation. Because blockers of glutamate receptors reliably reduce pain behaviour, it is assumed that 'pain' messages are mediated by glutamate action on dorsal horn neurons. The contribution of substance P, however, is still unclear. We have now disrupted the mouse preprotachykinin A gene (PPT-A), which encodes substance P and a related tachykinin, neurokinin A. We find that although the behavioural response to mildly painful stimuli is intact in these mice, the response to moderate to intense pain is significantly reduced. Neurogenic inflammation, which results from peripheral release of substance P and neurokinin A, is almost absent in the mutant mice. We conclude that the release of tachykinins from primary afferent pain-sensing receptors (nociceptors) is required to produce moderate to intense pain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9537322     DOI: 10.1038/32897

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  151 in total

1.  The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors.

Authors:  Karla P Zeitz; Nicolas Guy; Annika B Malmberg; Sahera Dirajlal; William J Martin; Linda Sun; Douglas W Bonhaus; Cheryl L Stucky; David Julius; Allan I Basbaum
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

Review 2.  Breathing: rhythmicity, plasticity, chemosensitivity.

Authors:  Jack L Feldman; Gordon S Mitchell; Eugene E Nattie
Journal:  Annu Rev Neurosci       Date:  2003-02-13       Impact factor: 12.449

3.  Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus.

Authors:  H Liu; A M Mazarati; H Katsumori; R Sankar; C G Wasterlain
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

4.  Detection of the full-length transcript variant for neurokinin-1 receptor in human whole blood associated with enhanced reinforcement of clot by substance-P.

Authors:  Toshiharu Azma; Yuki Sugimoto; Hiroyuki Kinoshita; Taishin Ito; Masanori Tsukamoto; Hiroshi Hoshijima; Masakazu Nakao; Hirosato Kikuchi
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

Review 5.  Transient receptor potential channels in pain and inflammation: therapeutic opportunities.

Authors:  Mark A Schumacher
Journal:  Pain Pract       Date:  2010-03-02       Impact factor: 3.183

6.  Opioid signaling in mast cells regulates injury responses associated with heterotopic ossification.

Authors:  Lixin Kan; Amelia A Mutso; Tammy L McGuire; Apkar Vania Apkarian; John A Kessler
Journal:  Inflamm Res       Date:  2013-12-11       Impact factor: 4.575

7.  Preprotachykinin-A gene disruption attenuates nociceptive sensitivity after opioid administration and incision by peripheral and spinal mechanisms in mice.

Authors:  Peyman Sahbaie; Xiaoyou Shi; Xiangqi Li; Deyong Liang; Tian-Zhi Guo; Yanli Qiao; David C Yeomans; Wade S Kingery; J David Clark
Journal:  J Pain       Date:  2012-10       Impact factor: 5.820

8.  Neurokinin B induces oedema formation in mouse lung via tachykinin receptor-independent mechanisms.

Authors:  Andrew D Grant; Roksana Akhtar; Norma P Gerard; Susan D Brain
Journal:  J Physiol       Date:  2002-09-15       Impact factor: 5.182

9.  Contribution of neurokinin 1 receptors in the cutaneous orofacial inflammatory pain.

Authors:  Philippe Luccarini; Mélaine Henry; Pedro Alvarez; Anne-Marie Gaydier; Radhouane Dallel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-27       Impact factor: 3.000

Review 10.  The recent progress in research on effects of anesthetics and analgesics on G protein-coupled receptors.

Authors:  Kouichiro Minami; Yasuhito Uezono
Journal:  J Anesth       Date:  2012-10-26       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.